JSM 2005 Online Program

JSM Activity #315

This is the preliminary program for the 2005 Joint Statistical Meetings in Minneapolis, Minnesota. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2005); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

The Program has labeled the meeting rooms with "letters" preceding the name of the room, designating in which facility the room is located:

Minneapolis Convention Center = “MCC” Hilton Minneapolis Hotel = “H” Hyatt Regency Minneapolis = “HY”

Back to main JSM 2005 Program page

Legend:

= Applied Session,

= Theme Session,

= Presenter


		Add To My Program
315	Tue, 8/9/05, 2:00 PM - 3:50 PM	MCC-200 I
Statistical Approaches for Benefit Risk Analysis - Topic Contributed - Papers
Biopharmaceutical Section, WNAR
Organizer(s): Yili Pritchett, Eli Lilly and Company
Chair(s): Kannan Natarajan, Bristol-Myers Squibb Company
2:05 PM	Benefit to Risk: Why, What, and How? — Christy Chuang-Stein, Pfizer, Inc.
2:25 PM	The Application of Global Benefit-Risk Score in Clinical Trial Design and Some Statistical Considerations of the Method — Yili Pritchett, Eli Lilly and Company; Roy Tamura, Eli Lilly and Company
2:45 PM	Global Benefit-risk Measure as a Tool for Drug Assessment — Richard Entsuah, Wyeth
3:05 PM	INB and WTP in the Benefit-risk Analysis of RCTs — Andrew Willan, Research Institute, Sick Kids
3:25 PM	Disc: Rodney Sparapani, Medical College of Wisconsin
3:45 PM	Floor Discussion